LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 40 filers reported holding LUMOS PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $403 | -64.5% | 122 | -64.5% | 0.00% | – |
Q2 2023 | $1,135 | -0.4% | 344 | 0.0% | 0.00% | – |
Q1 2023 | $1,139 | -8.3% | 344 | 0.0% | 0.00% | – |
Q4 2022 | $1,242 | -58.6% | 344 | 0.0% | 0.00% | – |
Q3 2022 | $3,000 | 0.0% | 344 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | -75.0% | 344 | -72.7% | 0.00% | – |
Q1 2022 | $12,000 | +50.0% | 1,262 | +2.9% | 0.00% | – |
Q4 2021 | $8,000 | -20.0% | 1,227 | +8.3% | 0.00% | – |
Q3 2021 | $10,000 | -16.7% | 1,133 | 0.0% | 0.00% | – |
Q2 2021 | $12,000 | -29.4% | 1,133 | -24.1% | 0.00% | – |
Q1 2021 | $17,000 | -46.9% | 1,492 | +64.9% | 0.00% | – |
Q4 2020 | $32,000 | +146.2% | 905 | -3.8% | 0.00% | – |
Q3 2020 | $13,000 | +85.7% | 941 | +111.5% | 0.00% | – |
Q2 2020 | $7,000 | +16.7% | 445 | -32.4% | 0.00% | – |
Q1 2020 | $6,000 | – | 658 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Minerva Advisors LLC | 34,015 | $321,000 | 0.21% |
Lion Point Capital, LP | 51,205 | $481,000 | 0.11% |
Wealth Advisors of Iowa, LLC | 11,699 | $110,000 | 0.06% |
NEA Management Company, LLC | 167,608 | $1,575,000 | 0.04% |
Paladin Advisory Group, LLC | 4,382 | $40,000 | 0.03% |
Marquette Asset Management, LLC | 13,315 | $125,000 | 0.03% |
Blackstone Inc. | 468,145 | $4,401,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $450,000 | 0.01% |
Jefferies Group LLC | 120,651 | $1,134,119 | 0.01% |
Renaissance Technologies | 271,712 | $2,554,000 | 0.00% |